ABSTRACT PTP1C, a protein-tyrosine-phosphatase (protein-tyrosine-phosphate phosphohydrolase, EC 3.1.3.48) containing two src homology 2 domains, is poorly active when assayed with various protein substrates in vitro. Its activity is stimulated >1000-fold by anionic phospholipids when myelin basic protein or mitogen-activated protein kinase is used as substrate but reduced in the presence of several other substrates. Data are presented to indicate a direct interaction ofthe enzyme with phospholipids. Enzyme stimulation directed only toward certain specific substrates is interpreted by assuming that these compounds also bind to the phospholipid vesicles where they will be subjected to rapid enzymatic attack. A possible regulation of PTP1C by its translocation to the cell membrane is hypothesized.
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Protein-tyrosine-phosphatases (PTPs; protein-tyrosinephosphate phosphohydrolase, EC 3.1.3.48) play a crucial role in cellular processes involving tyrosine phosphorylation (for review, see refs. 1 and 2). PTP1C (also referred to as SH-PTP1, HCP, SHP), a nontransmembrane phosphatase containing two src homology 2 (SH2) domains, is predominantly expressed in hematopoietic cells (3) (4) (5) (6) . It is homologous to the Drosophila enzyme corkscrew, identified as a positive transducer of the torso tyrosine kinase signal when acting in concert with the D-raf serine/threonine protein kinase (7) . Recently, another widely distributed SH2 domaincontaining phosphatase designated as SH-PTP2 or PTP2C has been described (8, 9) , suggesting the existence of a subfamily of such enzymes. SH2 domains are found in several types of signaling proteins, including a number of intracellular tyrosine kinases (for review, see refs. 10 and 11). They play a major role in signal transduction by allowing the interaction of these proteins with autophosphorylated growth factor receptors.
In an earlier study (12) , we reported the purification and characterization of recombinant PTP1C from an adenovirus expression system. Interestingly, the enzyme displayed very low specific activity toward several protein substrates as compared to other activated PTPs (<100 units/mg vs. >10,000 units/mg). The possibility that this low level of activity was due to an autoinhibitory reaction was supported by the observation that the enzyme was activated 20-fold by limited proteolysis (12) . A search was therefore undertaken for effectors that might bring about a similar activation without cleavage of the peptide chain. This manuscript reports that PTP1C is activated >1000-fold by selected phospholipids but only when specific proteins are used as substrates.
MATERIALS AND METHODS
Materials. Phosphatidic acid (PA), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylglycerol (PG), phosphatidylinositol (PI), phosphatidylserine (PS), cardiolipin (CL), diacylglycerol (DAG), sphingomyelin (Sph), arachidonic acid, p-nitrophenylphosphate (p-NPP), rabbit muscle enolase, trypsin, and soybean trypsin inhibitor were from Sigma. PTP1C was purified from an adenovirus expression system (12) and the soluble kinase domain of epidermal growth factor receptor (sEGFR) was from a baculovirus expression system (13 
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defined as the amount of enzyme causing the release of 1.0 nmol of phosphate per min.
Limited Trypsin Digestion of PTP1C. Proteolysis was carried out essentially as described (12) . Briefly, PTP1C at a final concentration of 0.4 mg/ml was preincubated for 2 min with 0.2 mg of the various phospholipids per ml or buffer alone and then treated with 0.2 ,g of trypsin per ml for different periods of time. The reaction was stopped by addition of 1 ,ug of soybean trypsin inhibitor per ml. Phosphatase activity was assayed as described above. The proteolysis products were analyzed on an SDS/15% polyacrylamide gel.
RESULTS
Effects of Various Phospholipids on the Activity of PTP1C. Fig. 1 illustrates the effects of PS on the activity of PTP1C. With MBP as substrate, enzymatic activity was increased at least 1000-fold at a lipid concentration of 25 ,g/ml. By contrast, the activity toward the commonly used RCMlysozyme, the nonapeptide ENDYINASL, or p-NPP was considerably reduced if not totally abolished.
A classic example of the regulation of an enzyme by phospholipids is the activation of protein kinase C (PKC) (19, 20) . Similar to the kinase, PTP1C was activated by anionic phospholipids including PA, PS, CL, PG, and PI but not by cationic phospholipids such as PC, PE, and Sph (Table 1) . Arachidonic acid, an activator of PKC, was also stimulatory, while DAG, the most powerful activator ofPKC, was without effect on the phosphatase. Among the lipids tested, PA was the most effective activator, followed, in decreasing order, by PS, CL, PI, PG, and arachidonic acid. The maximum specific activity obtained (-10,000 units/mg) is comparable to that reported for other PTPs toward the same substrate-namely, MBP. Furthermore, as observed for PS, all the anionic phospholipids inhibited the activity of PTP1C toward RCMlysozyme, ENDYINASL, orp-NPP, while PC, PE, Sph, and DAG had no effect (data not shown). As shown in Table 1 , addition of a second stimulatory phospholipid to PA or PS either slightly enhanced the activation or was without effect. PE, which was not stimulatory by itself, also enhanced the level of activation induced by PA or PS, while PC, Sph, and DAG remained ineffective.
To examine further the substrate specificity of the phospholipid-modulated PTP1C, several tyrosine-phosphorylated proteins of potential physiological relevance were tested as shown in Fig. 2 . In the absence of phospholipids, PTP1C displayed very low, if any, activity (<20 units/mg) toward sEGFR, PLC-y-SH2, enolase, BIRK, and ERK2. These low levels of activity were either unaffected (e.g., PLC-.oSH2 and enolase) or further reduced (e.g., sEGFR and BIRK) in the presence of phospholipids, except for ERK2. In the latter instance, addition of a mixture of PA and PS caused rapid and total tyrosine dephosphorylation of the substrate. Further studies with 0.3 ,uM purified phosphorylated ERK2 following a standard assay procedure as used for RCM-lysozyme and MBP revealed that PA, PG, PI, and PS (each at 50 ug/ml) increased the activity of the enzyme from 0.03 unit/mg to 50, 28, 36, and 22 units/mg, respectively. These values are times higher than that obtained when CD45 alone was used to dephosphorylate ERK2 (0.9 unit/mg). PC and PE remained ineffective.
As illustrated in Fig. 2 (three rightmost lanes), PTP1C is readily phosphorylated by BIRK and undergoes slow selfdephosphorylation. Unexpectedly, no enhancement of the autodephosphorylation reaction was brought about by the phospholipids; if anything, the reaction appeared to be inhibited.
Factors Affecting the Activation of PTP1C. Table 2 illustrates the factors affecting the activity of PTP1C. The phospholipids did not shift the pH optimum of the enzyme, which remained between pH 6.5 and 7.0. The activity of phospholipid-stimulated PTP1C increased with increasing concentrations of MBP but decreased after that. High concentrations of nonphosphorylated MBP reduced the level of activation even more. However, no such effect was observed in the absence of phospholipids. This may be indicative of the competition between MBP and the enzyme for phospholipid binding (21) . Bovine serum albumin, a carrier protein routinely included in the assay mixture, also appeared to interfere somewhat with the activation process since, when its concentration was reduced to 0.15 mg/ml, the stimulation was increased by nearly half. The activation did not require metal ions as the analyses were carried out in the presence of 1 mM EDTA. Excess Ca2+ and Mg2+ enhanced by 2-fold the activation brought about by PS but inhibited by nearly 80% the stimulation afforded by PA. Mn2+ and Zn2+ were inhibitory, and so was spermine. The basal activity of PTP1C toward MBP appeared to be insensitive to the inhibitory action of the classical inhibitors vanadate and heparin, but this conclusion could be misleading in view of the very low levels of activity displayed (12 for the other substrates. ERK2 was phosphorylated predominantly on tyrosine residues. For autodephosphorylation of PTP1C, excess EDTA was added to stop the phosphorylation reaction, and the reaction mixture was further incubated for 0 or 20 min with or without the addition of phospholipids. The molecular sizes of marker proteins (kDa) and the position of PTP1C are shown on the left and right, respectively.
decreased when assays were carried out in the presence of RCM-lysozyme, the ENDYINASL peptide, p-NPP, or several other protein substrates. These data could have suggested at first that the activation process was simply due to an interaction of the phospholipids with the substrates rather than with the enzyme. However, this is unlikely for the following reasons. First, the effects were specific for PTP1C and were not observed with any of the other phosphatases tested, including CD45, receptor PTPa, and wild-type human T-cell enzyme (TC-PTP) and its truncated form TCAC11 PTP (data not shown). Second, when activity measurements were performed for 30 sec instead of the usual 5 min, 8 times higher values were obtained when the enzyme rather than the substrate was preincubated with the phospholipids (Fig. 3) . Third, phospholipids greatly altered the proteolytic digestion pattern of the enzyme. As previously reported (12), a section containing 41 amino acids can be cleaved from the C terminus of PTP1C, leaving a trypsin-resistant core representing 93% of the molecule. This truncation was accompanied by a 20-fold increase in activity when the enzyme was assayed in the presence ofprotein substrates. As shown in Fig. 4 , tryptic attack in the presence of PA, PG, PI, or PS resulted in a rapid and extensive degradation of the phosphatase with total loss Table 2 . Factors affecting activity of PTP1C
PA PS Factor
No lipid (25 ,ug/ml) (25 Concentration of metal ions is in excess of that of EDTA.
of enzymatic activity. As expected, PC that had no stimulatory effect on PTP1C activity did not increase the susceptibility of the enzyme to tryptic attack. Likewise, phospholipids did not affect the rate of degradation of TC-PTP, another phosphatase activated by limited trypsinolysis (data not shown). These data suggest that those anionic phospholipids that activate PTP1C must do so by causing a significant change in the conformation of the enzyme. While limited trypsinolysis by itself caused a 20-fold activation of PTP1C, the truncated enzyme could be further activated by phospholipids to the same level as observed with the intact molecule, although an -5 times higher concentration of lipid was required ( Fig. 5 ; see also Fig. 1 ). This indicates that the C-terminal segment of the enzyme does not play a key role in the phospholipid-induced activation process.
DISCUSSION
The activation of PTP1C by phospholipids is too specific to be ascribed simply to a distortion of the molecule that would unmask the catalytic site. If this were the case, enzyme stimulation would be observed with all substrates tested. That the activation is restricted to the substrates MBP and MAP kinase can be interpreted by assuming that these two substrates also bind to phospholipid vesicles; their positioning in close proximity to enzyme would render them highly susceptible to enzymatic attack. The interaction of MBP with membrane phospholipids has been well documented (21 PTP1C would preferentially dephosphorylate those substrates that also interact with the membrane.
The negative charges provided by the anionic phospholipids on the surface of the artificial membrane vesicles must play a crucial role in the activation of PTP1C. Phospholipids are known to distribute asymmetrically on cell membranes (22) . For example, PC and Sph are preferentially located in the outer layer, while PS, PI, and PE are found in the inner layer. Such an asymmetric distribution would allow for regulation of PTP1C, assuming that the enzyme can associate with, or translocate to, the plasma membrane. While the recombinant PTP1C used in this study was purified from the cytosolic fraction of adenovirus-infected 293 cells (12) fatty acids stimulates its binding to phospholipids and causes its activation (26) .
MAP kinase (or ERK2) plays a crucial role in downstream signaling from growth factor receptors. Its activity is regulated by both tyrosine and threonine phosphorylation (27, 28) catalyzed by a MAP kinase kinase, which itself is reported to be controlled by another protein kinase-namely, raf-1 (29, 30) . While ERK2 is acted upon and inactivated by other PTPs including CD45, its rather specific dephosphorylation by the phospholipid-stimulated PTP1C could be of distinct physiological significance. The recent identification in Drosophila of a homolog of PTP1C (corkscrew) and the participation of this enzyme in signal transduction involving the torso and D-raf gene products might help to clarify this point (7) .
